enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Bedinvetmab - Wikipedia

   en.wikipedia.org/wiki/Bedinvetmab

   The most common side effects include increased blood urea nitrogen (an indicator of kidney function), urinary tract infection, bacterial skin infection, skin irritation (dermatitis), rash (erythema) or pain at injection site, vomiting (emesis), and weight loss (anorexia).

3. mRNA-4157/V940 - Wikipedia

   en.wikipedia.org/wiki/MRNA-4157/V940

   mRNA-4157/V940 is an mRNA based cancer vaccine. When administered, it will produce one of several dozen possible abnormal proteins commonly found in cancerous tissues. The production of those proteins is intended to invoke an immune response. mRNA-4157/V940 is given to patients after their tumors have been sequenced and abnormal proteins ...

4. List of therapeutic monoclonal antibodies - Wikipedia

   en.wikipedia.org/wiki/List_of_therapeutic...

   ovarian cancer, malignant ascites, gastric cancer cBR96-doxorubicin immunoconjugate: mab: humanized: Lewis-Y antigen: cancer Cedelizumab [47] mab: humanized: CD4: prevention of organ transplant rejections, treatment of autoimmune diseases Cemiplimab [32] Libtayo: mab: human: PD-1: Y: cutaneous squamous cell carcinoma Cergutuzumab amunaleukin ...

5. US FDA approves ImmunityBio's bladder cancer therapy - AOL

   www.aol.com/news/u-fda-approves-immunitybios...

   The drug is used in combination with the Bacillus Calmette-Guérin (BCG) vaccine, which is mainly used against tuberculosis, but also as a common treatment for some forms of bladder cancer.

6. Passive antibody therapy - Wikipedia

   en.wikipedia.org/wiki/Passive_antibody_therapy

   Passive antibody administration has become a widely approved cancer treatment following the development of monoclonal antibody (mAb). Since these antibodies originated from mice, they were wrought with problems of immunogenetics and poor abilities to induce an immune response in the human body, limiting their clinical applicability. [ 12 ]

7. CimaVax-EGF - Wikipedia

   en.wikipedia.org/wiki/CimaVax-EGF

   CimaVax is an active vaccine with which patients are immunized with epidermal growth factor (EGF), thus raising antibodies targeting EGF itself. The EGF is chemically linked to the Neisseria meningitidis outer protein P64k for immunogenicity; [2] Montanide ISA 51 is used as an adjuvant to potentiate the immune response.

8. Monoclonal antibody therapy - Wikipedia

   en.wikipedia.org/wiki/Monoclonal_antibody_therapy

   Anti-cancer monoclonal antibodies can be targeted against malignant cells by several mechanisms. Ramucirumab is a recombinant human monoclonal antibody and is used in the treatment of advanced malignancies. [18] In childhood lymphoma, phase I and II studies have found a positive effect of using antibody therapy. [19]

9. Personalized cancer vaccine results are a 'home run ... - AOL

   www.aol.com/finance/personalized-cancer-vaccine...

   The duo have partnered since 2016 with a focus on cancer, where Merck is a dominant player for therapies, but the Phase 2 results are the first promising for a any cancer vaccine.